Iwona Dachowska-Kałwak
Biographic Data
| ID | 8252613 |
|---|---|
| NAME | Iwona Dachowska-Kałwak |
| GIVEN NAMES | Iwona |
| FAMILY NAME | Dachowska-Kałwak |
| SIGNATURE | DACHOWSKA-KAŁWAK I |
| AFFILIATIONS | Wroclaw Medical University |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Neuroblastoma Presenting as a Congenital Renal Mass in a Neonate
Neuroblastoma should be considered in the differential diagnosis of congenital "renal" masses. Imaging-driven provisional diagnoses may be misleading, and genomic risk profiling may help lower the threshold for systemic therapy in selected cases
Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terventions could be potentially molecularly guided as vulnerabilities to BH3-mimetics were re-ported. Currently venetoclax is not incorporated into paedi…
No prominent works on this page.
Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terventions could be potentially molecularly guided as vulnerabilities to BH3-mimetics were re-ported. Currently venetoclax is not incorporated into paedi…
Neuroblastoma Presenting as a Congenital Renal Mass in a Neonate
Neuroblastoma should be considered in the differential diagnosis of congenital "renal" masses. Imaging-driven provisional diagnoses may be misleading, and genomic risk profiling may help lower the threshold for systemic therapy in selected cases
Acute Lymphoblastic Leukemia research (1 work) · Acute Myeloid Leukemia Research (1 work) · Cancer (1 work) · Chronic Lymphocytic Leukemia Research (1 work) · Congenital disease (1 work) · Context (archaeology (1 work) · Differential diagnosis (1 work) · Family medicine (1 work) · Internal Medicine (1 work) · Intervention (counseling (1 work)